B. Braun orders two DrugLog™ for new installations in Spain

B. Braun Medical Spain orders DrugLog™ systems for quality control of compounded medications in 2 additional hospitals.

B. Braun Medical Spain orders two complete DrugLog™ systems based on the new hardware platform for installation at additional hospitals in Spain. The DrugLog™ systems will be used to verify the identity and concentration of prepared injectable drugs before they are administered to patients and will contribute to increased patient safety.

Lars Gusch, CEO of Pharmacolog comments: “We are very pleased to deliver Pharmacolog’s products to two more of B.Braun’s customers in Spain. With this latest order from our partner B.Braun, there will soon be 8 DrugLog™ systems for quality control of pharmaceutical preparations operational in hospitals in Spain. This will reduce the risks of medication errors to the great benefit of both patients and healthcare professionals.”

For more information contact:

Lars Gusch, CEO

Email: lars.gusch@pharmacolog.com
Phone: +46
70-223 97 72


About Pharmacolog

Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.

The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.

Further information regarding the company is available at https://pharmacolog.com/.

The company’s Certified Adviser is Mangold Fondkommission AB.

Release

Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.